Advertisement

Topics

Latest "Immersion Corp." News Stories

06:29 EST 17th February 2019 | BioPortfolio

Here are the most relevant search results for "Immersion Corp." found in our extensive news archives from over 250 global news sources.

More Information about Immersion Corp. on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Immersion Corp. for you to read. Along with our medical data and news we also list Immersion Corp. Clinical Trials, which are updated daily. BioPortfolio also has a large database of Immersion Corp. Companies for you to search.

Showing "Immersion Corp" News Articles 1–25 of 127

Thursday 14th February 2019

Martin Åmark, CEO for Xbrane Biopharma AB, becomes Head of IR for the Company

Press release2019-02-14 Martin Åmark, CEO of Xbrane Biopharma AB ("Xbrane"), will as of today also be the Head of IR for Xbrane. The reason for this is that Xbrane's current Head of IR and CFO, Susanna Helgesen, will be on parental leave on a part-time basis for a period. During the parental leave, Susanna Helgesen will remain as CFO. The finance team has also bee...


Active Biotech Year-end report January - December 2018

          Fourth quarter in brief Active Biotech communicated updated information about its financial position New data from the LEGATO-HD study presented at the 2018 HSG conference Other significant events during the January-December period Patent regarding tasquinimod for the treatment of multiple myeloma (MM) granted in the US

Wednesday 13th February 2019

Blueberries Medical Corp Enters into Letter of Intent With El Manantial Medical Centers for Rapid Product Commercialization & Patient Acquisition; To Build Two Pharmacies to Support JV

TORONTO, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (the “Company” or "Blueberries"), a leading Colombia-based licenced producer of medicinal cannabis and cannabis-derived products, has entered into a letter of intent (the “Letter Agreement”) dated February 13, 2019 for a joint venture (the “Joint Venture”) with Harmony and Life S.A.S., operating as El Ma...


#Cannabisstocks: CannAmerica (CSE: CANA) (OTCQB: CNNXF) Comments on the State of Colorado Reaching $6 Billion in #Cannabis Sales

VANCOUVER - February 13, 2019 (Investorideas.com Newswire) Dan Anglin, Co-Founder and CEO of CANNAMERICA BRANDS CORP. ("CannAmerica Brands" or the "Company") (CSE: CANA) (OTCQB: CNNXF), commented on the state of Colorado surpassing USD$6 billion in cannabis sale since January 1, 2014

Monday 11th February 2019

Yuhan Corp and Sorrento Therapeutics Announce Closing of a $40m USD Financing for Joint Venture ImmuneOncia to Support Advancement of Immuno-Oncology Program

SEOUL, South Korea and SAN DIEGO, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Yuhan Corporation (000100.KS; Yuhan) and Sorrento Therapeutics (Nasdaq: SRNE) announced today that ImmuneOncia, a joint venture formed in September 2016, has completed a private equity financing of $40 million USD at a pre-money valuation of $95 million USD, which was led by Paratus SP (Private Equity Fund).  The proceeds of...

Active Biotech's partner NeoTX enters clinical collaboration with AstraZeneca to evaluate ANYARA in combination with IMFINZI® (durvalumab) in the upcoming Phase 1b/2 study

PRESS RELEASE Lund Sweden, February 11 2019 - Active Biotech (NASDAQ STOCKHOLM: ACTI) announces that their partner NeoTX enters a clinical collaboration with AstraZeneca Group Plc (NYSE: AZN) global biologics research and development arm, MedImmune, to support Phase 1b/2 studies investigating ANYARA in combination with AstraZeneca's IMFINZI®. IMFINZI® (durvalumab) is a human...

Sunday 10th February 2019

Helix BioPharma Corp. Provides Clinical Development and Strategic Corporate Update

RICHMOND HILL, Ontario, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (FSE: HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer today provides an update on the Company’s strategic plans. Pre-clinical Development The Company extended its collaboration with the Moffitt Cance...

Thursday 7th February 2019

Helix BioPharma Corp. Board Changes

RICHMOND HILL, Ontario, Feb. 08, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP) (FSE: HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced a change in the Company’s Board of Directors. The Board has accepted the resignation of Dr. Marek Orlowski as a director of the ...

Monday 4th February 2019

CDN MSolar and Blueberries Cannabis Complete Business Combination to Form Blueberries Medical Corp; Shares to Commence Trading February 6, 2019 Under the Symbol “BBM”

TORONTO, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (the “Company” or "Blueberries") is pleased to announce the completion of its business combination with Blueberries Cannabis Corp. (the "Private Company"), a leading Colombia-based licenced producer of medicinal cannabis and cannabis-derived products (the "Transaction"). Trading in the common shares of Blueberri...

Emblem Corp. Announces Receipt of Interim Court Order and Mailing of Meeting Materials Related to its Special Meeting of Shareholders and Proposed Arrangement with Aleafia Health Inc.

TORONTO, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”) announces that the Ontario Superior Court of Justice (Commercial List) granted the Company’s motion for an interim order authorizing various matters, including the mailing of a management information circular (the “Circular”) and the holding of the special meeting of Emble...

Oxurion NV to Present at the 2019 BIO CEO & Investor Conference

Leuven, Belgium, 4 February 2019 - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing innovative treatments to preserve vision in patients with diseases affecting the back of the eye, announced today that Patrik De Haes, M.D., chief executive officer, will present a company overview and clinical update at the 2019 BIO CEO & Investor Conference. The pres...

CannAmerica Brands (CSE: CANA) (OTCQB: CNNXF) CEO Dan Anglin Named to High Times' List of the 100 Most Influential People In Cannabis

LAS VEGAS - February 4, 2019 (Investorideas.com Newswire) Dan Anglin, Co-Founder & CEO of CANNAMERICA BRANDS CORP. ("CannAmerica" or the "Company") (CSE: CANA) (OTCQB: CNNXF), maker of one of the most iconic infused confections in legal cannabis, has been named one of the High Times 100 Most Influential People in the Cannabis Industry.

Friday 1st February 2019

Active Biotech has received an indicative bid for the property in Lund - the Board is positive

As previously reported, Active Biotech's property Forskaren 1 in Lund has been on sale for a period of time. Active Biotech has now received an indicative, non-binding bid for the property, amounting to SEK 275 million from a newly formed investor collective led by the real estate company Estea AB (Estea). The bid corresponds to the property's book value. Active Biotec...

Wednesday 30th January 2019

Global Internal Nasal Dilators Market Research Report 20122024 [Report Updated: 01011970] Prices from USD $1800

The global Internal Nasal Dilators market will reach Volume Million USD in 2017 with CAGR xx% 20192023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.Based on products type, the report describes m...

Monday 28th January 2019

#Cannabisstocks: CannAmerica (CSE: CANA) (OTCQB: CNNXF) and Invictus (TSXV: GENE; OTCQX) Provide Update on #Hemp and #CBD Joint Venture

VANCOUVER - January 28, 2019 (Investorideas.com Newswire) CANNAMERICA BRANDS CORP. ("CANA" or the "Company") (CSE: CANA) (OTCQB: CNNXF) is pleased to provide an update on its binding letter of intent to create a joint venture with Invictus MD Strategies Corp. ("Invictus") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) and CBDistribution Company Ltd. ("CBDC") (collectively the "Joint Venture") that was prev...

Sunday 27th January 2019

Helix BioPharma Corp. Extends Annual Meeting Date

RICHMOND HILL, Ontario, Jan. 28, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: “HBP”) (“Helix”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced that it has received consent from the Toronto Stock Exchange to extend the date of its annual general meeting of shareholders to a date not later than Apri...

Monday 21st January 2019

CFN Media's Exclusive Interview with Aleafia Health CEO Geoffrey Benic Discussing Emblem Corp. Acquisition

SEATTLE, Jan. 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article featuring Aleafia Health Inc’s. (TSX-V: ALEF) (OTCQX: ALEAF) (FRA: ARAH) CEO Geoffrey Benic discussing the company’s acquisition of Emblem Corp. creating Canad...

Friday 18th January 2019

Xbrane Biopharma announces acceptance of initiation of Xlucane clinical trial in the US

Press release2019-01-18 The Food and Drug Administration (FDA) and the Central Ethics Committee in the United States have accepted Xbranes IND application for initiation of the Xplore trial, a phase III trial with Xlucane, a ranibizumab (Lucentis®) biosimilar candidate. "It is with great satisfaction we can announce acceptance from the FDA and the Central Ethics Committee...

Thursday 17th January 2019

Tattoos May be Cool, but Could Prove Hazardous to Skin and General Health

Allergist Dr. David Erstein with Advanced Dermatology PC offers tips for proper care of tattoo to minimize risks. ALBERTSON, N.Y. (PRWEB) January 17, 2019 Tattoos may seem cool but turning skin into a canvas for artwork, messages and permanent cosmetic designs poses health risks, some of which can prove serious. That’s the word of caution from David Erstein MD, of New York- and New Jersey-based...

Tuesday 8th January 2019

Cannamerica (CSE: CANA) (OTCQB: CNNXF) And Invictus (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) Combine To Enter #Hemp And #CBD Market In The US

VANCOUVER - January 8, 2019 (Investorideas.com Newswire) CANNAMERICA BRANDS CORP. ("CannAmerica" or the "Company") (CSE: CANA) (OTCQB: CNNXF) is pleased to announce that it has entered into a binding letter of intent ("LOI") to create a joint venture with Invictus MD Stategies Corp. ("Invictus") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) and CBDistribution Company Ltd. ("CBDC") with the intention of ac...

Friday 4th January 2019

PSB Holding Corp. Declares Stock Split

PRESTON, Md., Jan. 4, 2019 /PRNewswire/ -- PSB HOLDING CORP. (OTCQX: PSBP) today announced that its Board of Directors declared a two and a half-for-one Read more...

Thursday 27th December 2018

Helix BioPharma Corp. Closes Final Tranche of Private Placement

RICHMOND HILL, Ontario, Dec. 28, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX, FSE: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced it has closed a final tranche of a private placement financing for gross proceeds of CAD348,000. The terms of the placement are ...

#Cannabisstocks: CannAmerica (CSE: CANA) (OTCQB: CNNXF) Announces Trading on the #OTCQB

VANCOUVER - December 27, 2018 (Investorideas.com Newswire) CANNAMERICA BRANDS CORP. ("CannAmerica" or the "Company") (CSE: CANA) (OTCQB: CNNXF) is pleased to announce that its common shares have commenced trading on the OTCQB Venture Market in the United States under the symbol "CNNXF" on December 27, 2018.

Monday 24th December 2018

Empower and Awaken to a Thriving Life with Anahata Ananda in Breathtaking Sedona, Arizona

Shamangelic Healing's world renowned Empowerment and Awakening Weekend Intensive is now open for registration. Anahata Ananda's powerful courses share the tools necessary to empower students to create the life of their dreams! SEDONA, Ariz. (PRWEB) December 24, 2018 Anahata Ananda, founder of Shamangelic Healing, announces her Empowerment and Awakening Weekend Intensive is now open for re...

Friday 21st December 2018

Virginia G. Piper Charitable Trust Announces 2018 Piper Fellows

Five Nonprofit Innovators Receive Transformational Fellowships Virginia G. Piper Charitable Trust has named its 18th class of Piper Fellows—five outstanding nonprofit leaders with diverse backgrounds who are dedicated to improving and enriching health, well-being, and opportunity for the people of Maricopa County. This press release features multimedi...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks